drugset / Trial / NCT02259803
Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
Study to investigate the relative bioavailability of fixed-dose combination tablet vs. mono-components of telmisartan and amlodipine
Timeline
- Start
- 2007-10
- Primary completion
- 2007-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 40 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 80 mg | Oral |
Indications
No indication recorded.